{
  "abstract": "Glaucoma is a major public health issue in ophthalmology. Despite advances in diagnostics and treatment, it continues to be the leading cause of irreversible blindness worldwide1 and second in high-income countries.2 The silent nature of primary open-angle glaucoma with almost no symptoms in early stages leads to a significant proportion of individuals undiagnosed until significant vision loss has already occurred.",
  "authors": [
    {
      "affiliations": [
        "Department of Ophthalmology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Rhineland-Palatinate, Germany"
      ],
      "name": "Alexander K. Schuster"
    },
    {
      "affiliations": [
        "CHU Bordeaux, Department of Ophthalmology, Univ. Bordeaux, INSERM, Bordeaux Population Health Research Center, team LEHA, UMR 1219, F-33000, France"
      ],
      "name": "Cedric Schweitzer"
    }
  ],
  "title": "Rising glaucoma burden demands evidence-based strategies",
  "uid": "bf5259f3-e7ce-50f3-9ae0-0b2e2d16f924"
}